Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.71 +0.12 (+1.58%)
As of: Oct 21, 2026 · 2:29 PM EDT

Eupraxia Pharmaceuticals (EPRX) Current Taxes (2022)

Updated

Eupraxia Pharmaceuticals' Current Taxes came in at $8.74 million for the quarter ended Dec 31, 2022.

Analysis

Eupraxia Pharmaceuticals (EPRX) Current Taxes (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,135.99 Bn 1,104.58 Bn 19.71 Bn -
2 Johnson & Johnson 616.90 Bn 535.42 Bn 17.26 Bn 1.05 Bn
3 AbbVie 501.56 Bn 474.68 Bn 12.70 Bn -
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 261.45 Bn 235.13 Bn 12.86 Bn 1.47 Bn
7 Amgen 236.48 Bn 191.88 Bn 7.24 Bn -
8 Gilead Sciences 190.56 Bn 164.76 Bn 6.22 Bn -
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 653.00 Mn
10 Eupraxia Pharmaceuticals 308.06 Mn -134.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 8.74 Mn
API Access

Eupraxia Pharmaceuticals Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=EPRX&period=max&api_key=YOUR_API_KEY